Patent fight in India centers on AIDS drug

May 11, 2006

A patent application covering tenofovir, a major AIDS drug, has started a major patent fight in India.

If the drug is granted a patent, the manufacture of cheaper versions of tenofovir in India will become illegal, making the drug too expensive for many patients in developing nations, The International Herald Tribune reported Thursday.

The suit challenges Indian patent laws designed to control that country's large pharmaceutical industry, which has long specialized in making cheaper copies of Western manufactured medicines, the newspaper said.

The Indian patent office says it has received about 9,000 patent applications, most from international pharmaceutical companies.

But patient advocates warn the developing world's access to a wide range of vital generic drugs made in India might become jeopardized.

The Delhi Network of Positive People and the Indian Network for People Living with HIV/AIDS filed a formal protest Tuesday to a patent application from U.S.-based Gilead Sciences for the drug tenofovir.

The patient rights group argues tenofovir is not a new drug, just a modified version of an earlier drug, and therefore is not eligible for a new patent under India's laws.

Copyright 2006 by United Press International

Explore further: US group seeks to block Gilead drug patent in India

Related Stories

US group seeks to block Gilead drug patent in India

November 24, 2013
A US-based patient rights group said Saturday it has sought to block a bid by California-based Gilead Sciences to obtain an Indian patent for a potentially blockbuster drug to treat hepatitis C.

India licenses generic copy of patented Bayer drug

March 12, 2012
(AP) -- India effectively ended Bayer's monopoly on a patented cancer drug Monday, licensing a much cheaper generic under a unique law aimed at keeping costs affordable.

India patent case threatens cheap drug supply: MSF

September 5, 2011
Supply of cheap, copycat drugs for the developing world could be badly threatened if Swiss firm Novartis wins a challenge to India's patent law, medical charity MSF said on Monday.

Gilead wins India patent for blockbuster Hepatitis drug

May 10, 2016
India has granted a patent to US pharmaceutical giant Gilead for a blockbuster Hepatitis C drug, in a U-turn activists said could potentially stop affordable copies reaching millions of people in other countries.

Drug maker Novartis loses India patent battle (Update)

April 1, 2013
India's Supreme Court on Monday rejected drug maker Novartis AG's attempt to patent an updated version of a cancer drug in a landmark decision that health activists say ensures poor patients around the world will get continued ...

India's rejection of drug patent could reverberate

April 1, 2013
The India Supreme Court's rejection of a patent for an improved version of a costly cancer drug by Novartis AG could have big implications for the world's largest drugmakers.

Recommended for you

Do you see what I see? Researchers harness brain waves to reconstruct images of what we perceive

February 22, 2018
A new technique developed by neuroscientists at the University of Toronto Scarborough can, for the first time, reconstruct images of what people perceive based on their brain activity gathered by EEG.

DNA gets away: Scientists catch the rogue molecule that can trigger autoimmunity

February 22, 2018
A research team has discovered the process - and filmed the actual moment - that can change the body's response to a dying cell. Importantly, what they call the 'Great Escape' moment may one day prove to be the crucial trigger ...

Low-calorie diet enhances intestinal regeneration after injury

February 22, 2018
Dramatic calorie restriction, diets reduced by 40 percent of a normal calorie total, have long been known to extend health span, the duration of disease-free aging, in animal studies, and even to extend life span in most ...

Fertility breakthrough: New research could extend egg health with age

February 22, 2018
Women have been told for years that if they don't have children before their mid-30s, they may not be able to. But a new study from Princeton University's Coleen Murphy has identified a drug that extends egg viability in ...

Beetroot juice supplements may help certain heart failure patients

February 22, 2018
Beetroot juice supplements may help enhance exercise capacity in patients with heart failure, according to a new proof-of-concept study. Exercise capacity is a key factor linked to these patients' quality of life and even ...

Neuroscientists discover a brain signal that indicates whether speech has been understood

February 22, 2018
Neuroscientists from Trinity College Dublin and the University of Rochester have identified a specific brain signal associated with the conversion of speech into understanding. The signal is present when the listener has ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.